Forecast: (IDXX) for 2023-2027
Updated: October 26, 2023
An Insight into IDEXX Laboratories, Inc.
Last trading day: 01/01/1970
Analyst forecast price: $506.14
52-week high/low: $706.51 / $318.5
On the global stage, IDEXX Laboratories, Inc. commands attention, with its shares actively traded under the ticker IDXX. A notable entity in the "Healthcare" sector, it showcases a blend of innovation and market resilience. Nestled at ONE IDEXX DRIVE, WESTBROOK, ME, US, the head office stands as a nexus where strategic decisions and innovations emanate. It boasts a market capitalization of $33 533 993 000, reflecting its substantial footprint in the industry. With 84 007 000 shares oscillating in the vibrant market, every transaction echoes the company’s undeterred progression. A glimpse into the last fiscal year reveals EBITDA standing at 1 038 800 000$. This financial robustness underscores profitability and sustainable business acumen. The spotlight also shines on the PE ratio, positioned at 46.8. It translates to an investment payback period of roughly 47 years, casting light on profitability timelines. This stretches into a long-term financial commitment, tailored for investors with a speculative and patient approach.
Engaging in a deeper analytical discourse, investors and market watchers alike often turn to resources like Allforecast.com. Here, comprehensive insights, data analytics, and predictive metrics about companies like IDEXX Laboratories, Inc. are made available. This rich reservoir of information aids in informed decision-making, blending historical data with future predictions to paint a holistic picture of stock performance trajectories.
Unraveling IDEXX Laboratories (IDXX) Stock Predictions for 2026
In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing IDEXX Laboratories and its promising trajectory, we have meticulously collated insights from various analyst forecasts. Our consensus forecast for 2026 is a composite reflection of diverse expert analyses, ensuring a balanced and informed perspective for potential investors and market enthusiasts.
We encapsulate our insights visually, offering a detailed forecast chart for IDEXX Laboratories in 2026. This visual representation is a blend of historical and projected data, offering a comprehensive view of the stock’s performance. The grey trajectory delineates the historical performance of IDXX, while the turquoise trajectory illuminates the anticipated performance, encapsulating potential fluctuations and trends.
At Allforecast.com, we go beyond conventional data presentation. Our analyses are ingrained with depth, offering not just numbers but insights that empower informed decision-making. For IDEXX Laboratories, each data point, each trend, and each projection is a story of potential opportunities, risks, and strategic decisions. Navigate through the intricate world of stocks with data that is as comprehensive as it is precise.
Analyzing the anticipated performance of IDEXX Laboratories, the ceiling value that the stock is expected to reach in 2026 stands at a promising $632.24. Indicating a bullish trend, an upside potential of 47.61% signals profitable prospects, with an average monthly return of 1.25%, beckoning investors to consider amplifying their portfolios.
On the flip side, the floor value that IDEXX Laboratories stock may plummet to in 2026 is $349.71. Highlighting a potential decline of 22.48%, cautious investment and vigilant monitoring become paramount.
In the grand scheme, a price oscillation channel for IDEXX Laboratories is foreseeable, bounded by a resistance level of $632.24 and a support frontier at $349.71. This fluctuation breadth of $282.53 presents nuanced investment gateways and exit junctures, pivotal for strategic stock trading.
The pendulum of market dynamics sways amidst myriad factors. The juxtaposition of historical trends, current market sentiments, and forward-looking analytics offers a comprehensive panorama. The breakout potential, trajectory sustenance, and market volatilities are intrinsically tied to economic indicators, policy shifts, and industry innovations. For IDEXX Laboratories, every forecast, every percentage point, and every market prediction is not just a statistical data point but a narrative woven into the fabric of its corporate journey. As investors and market watchers alike toggle between optimism and caution, each prediction, each high and low, charts the course of IDEXX Laboratories in the bustling marketplace.
Ascend or descend, each move of IDEXX Laboratories stock is a pulse in the financial markets, echoing the rhythms of economic cycles, investor sentiments, and market dynamics. With the dawn of each trading day, new opportunities and challenges emerge, painting a vibrant tapestry of IDEXX Laboratories's stock trajectory in the canvas of global finance.
Let’s delve into an analytical exploration of the support level's robustness for IDEXX Laboratories stocks. The stock is projected to hover around the support level for 2 months, reflecting the temporal dynamics of IDEXX Laboratories's stock price. This pattern insinuates minimal volatility, indicating a stabilized stock performance.
Furthermore, it's pivotal to consider that the actual future valuation of IDEXX Laboratories shares is susceptible to market volatilities and can oscillate both above and below the anticipated forecast price. Yet, it is generally anticipated to oscillate within the confines of the pessimistic and optimistic target price projections. This nuance is integral for investors aiming for balanced portfolio diversification and risk mitigation.
Each projection and statistical insight into IDEXX Laboratories's performance not only informs investment strategies but also adds a layer to the unfolding narrative of its market journey. As numbers dance and trends oscillate, every investor, analyst, and market enthusiast becomes a witness to the dynamic ballet of figures, forecasts, and financial crescendos that define the stock’s story.
| Month | Mid | Low | High | Range, % |
|---|---|---|---|---|
| January 2026 | 526.75 | 512.43 | 550.40 | 6.90 % |
| February 2026 | 494.52 | 480.06 | 518.06 | 7.33 % |
| March 2026 | 475.01 | 452.08 | 498.59 | 9.33 % |
| April 2026 | 481.80 | 457.88 | 495.23 | 7.54 % |
| May 2026 | 477.87 | 468.77 | 489.89 | 4.31 % |
| June 2026 | 494.11 | 471.27 | 519.65 | 9.31 % |
| July 2026 | 479.66 | 467.60 | 495.00 | 5.54 % |
| August 2026 | 497.93 | 481.68 | 522.65 | 7.84 % |
| September 2026 | 514.86 | 499.46 | 528.51 | 5.50 % |
| October 2026 | 543.22 | 516.99 | 552.82 | 6.48 % |
| November 2026 | 574.62 | 565.24 | 603.53 | 6.34 % |
| December 2026 | 606.27 | 580.71 | 632.24 | 8.15 % |
Forecast for January 2026.
It is predicted that the price of one IDEXX Laboratories share in will be in the range of $512.43 to $550.40. The width of this range will be $37.97 (6.90%). The average price is $526.75, which is $32.28 higher than the average price of the previous month.
Forecast for February 2026.
It is predicted that the price of one IDEXX Laboratories share in will be in the range of $480.06 to $518.06. The width of this range will be $38.00 (7.33%). The average price is $494.52, which is $32.24 less than the average price of the previous month.
Forecast for March 2026.
It is predicted that the price of one IDEXX Laboratories share in will be in the range of $452.08 to $498.59. The width of this range will be $46.51 (9.33%). The average price is $475.01, which is $19.5 less than the average price of the previous month.
Forecast for April 2026.
It is predicted that the price of one IDEXX Laboratories share in will be in the range of $457.88 to $495.23. The width of this range will be $37.35 (7.54%). The average price is $481.80, which is $6.78 higher than the average price of the previous month.
Forecast for May 2026.
It is predicted that the price of one IDEXX Laboratories share in will be in the range of $468.77 to $489.89. The width of this range will be $21.12 (4.31%). The average price is $477.87, which is $3.93 less than the average price of the previous month.
Forecast for June 2026.
It is predicted that the price of one IDEXX Laboratories share in will be in the range of $471.27 to $519.65. The width of this range will be $48.38 (9.31%). The average price is $494.11, which is $16.25 higher than the average price of the previous month.
Forecast for July 2026.
It is predicted that the price of one IDEXX Laboratories share in will be in the range of $467.60 to $495.00. The width of this range will be $27.40 (5.54%). The average price is $479.66, which is $14.45 less than the average price of the previous month.
Forecast for August 2026.
It is predicted that the price of one IDEXX Laboratories share in will be in the range of $481.68 to $522.65. The width of this range will be $40.97 (7.84%). The average price is $497.93, which is $18.27 higher than the average price of the previous month.
Forecast for September 2026.
It is predicted that the price of one IDEXX Laboratories share in will be in the range of $499.46 to $528.51. The width of this range will be $29.06 (5.50%). The average price is $514.86, which is $16.93 higher than the average price of the previous month.
Forecast for October 2026.
It is predicted that the price of one IDEXX Laboratories share in will be in the range of $516.99 to $552.82. The width of this range will be $35.83 (6.48%). The average price is $543.22, which is $28.36 higher than the average price of the previous month.
Forecast for November 2026.
It is predicted that the price of one IDEXX Laboratories share in will be in the range of $565.24 to $603.53. The width of this range will be $38.29 (6.34%). The average price is $574.62, which is $31.4 higher than the average price of the previous month.
Forecast for December 2026.
It is predicted that the price of one IDEXX Laboratories share in will be in the range of $580.71 to $632.24. The width of this range will be $51.53 (8.15%). The average price is $606.27, which is $31.65 higher than the average price of the previous month.